Novel Molecular Therapies Appendix

Publication
Article
OncologyONCOLOGY Vol 20 No 13
Volume 20
Issue 13

appendix

Download the Appendix as a PDF.

Articles in this issue
Acute Myeloid Leukemia in the Elderly: A Unique Disease
Adjuvant Therapy for Early Lung Cancer: Reflections and Perspectives
What Defines an 'Elderly Patient With AML'?
Thirty Years Later: We've Only Just Begun
Management of Early-Stage Lung Cancer: Past, Present, and Future Adjuvant Trials
Progress With a Purpose: Eliminating Suffering and Death Due to Cancer
Teleoncology Extends Access to Quality Cancer Care
Does This Woman Have Gestational Trophoblastic Disease?
Managing Acute Myeloid Leukemia in the Elderly
Prevention of Colorectal Cancer: An Emerging Role for High-Dose Vitamin D Supplementation?
Commentary (Knoop): Understanding Novel Molecular Therapies
Understanding Novel Molecular Therapies
Toxicity of Targeted Therapy
Recognizing and Managing Side Effects Associated With Novel Targeted Therapies:
Novel Molecular Therapies Appendix
Recent Videos
Related Content
Multiple Myeloma Experts Face Off on Sequencing Therapy Options

Multiple Myeloma Experts Face Off on Sequencing Therapy Options

ONCOLOGY Staff
November 21st 2024
Article

Experts in multiple myeloma gathered to debate current treatment options in the space during a recent Face Off.

Stem Cell Transplant Approaches for Patients With Blood Cancers

Stem Cell Transplant Approaches for Patients With Blood Cancers

David T. Scadden, MD
March 13th 2019
Podcast

Dr. Scadden discusses which blood cancer patients are eligible for stem cell transplantation, as well as the latest advances in the field.

Addressing Gaps in Education for Non–Clear Cell RCC

Addressing Gaps in Education for Non–Clear Cell RCC

ONCOLOGY Staff
November 19th 2024
Article

A panel discussed on RCC and the differentiation in the identification and treatment of clear and non-clear cell RCC.

Current Treatment of Esophageal Cancer and Promising Clinical Trials Underway

Current Treatment of Esophageal Cancer and Promising Clinical Trials Underway

Geoffrey Y. Ku, MD
March 13th 2019
Podcast

Dr. Ku discusses considerations in the treatment of esophageal cancer, current treatments, and the emerging role of immunotherapy.

BTK Inhibitor Treatment Options Across the Lymphoma Landscape

BTK Inhibitor Treatment Options Across the Lymphoma Landscape

ONCOLOGY Staff
November 17th 2024
Article

Clinicians focused on CLL, follicular lymphoma, and MCL gathered during a Frontline Forum to discuss the use of BTKi in each respective disease state.

T-DXd Sequencing and Treatment Options in the Tumor-Agnostic Setting

T-DXd Sequencing and Treatment Options in the Tumor-Agnostic Setting

ONCOLOGY Staff
November 15th 2024
Article

HER-directed treatment approaches in the tumor-agnostic field were the highlight of the discussion for a panel of experts who convened at WCLC 2024.